ANDA Submissions -- Refuse-to-Receive Standards Rev2
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 28, 2016
April 21, 2020
78b570c1-44d2-45b3-b780-47480621496b
Related Documents
Determining Whether to Submit an ANDA or a 505(b)(2) Application
Guidance DocumentMay 10, 2019Center for Drug Evaluation and Research
Botanical Drug Development: Guidance for Industry
Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
Nonprescription Sunscreen Drug Products – Format and Content of Data Submissions
Guidance DocumentNovember 23, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.